Opportunity
DIBBS #SPE2DP-26-T-5353
DLA request for 22 bottles of moxifloxacin hydrochloride tablets
Posted
September 30, 2026
Respond By
October 05, 2026
Identifier
SPE2DP-26-T-5353
NAICS
424210
DLA Troop Support is seeking 22 bottles of moxifloxacin hydrochloride tablets for pharmaceutical supply requirements. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA. - OEMs / approved sources: Teva Pharmaceuticals USA, Inc. (NDC 00093-7387-56) and Rising Pharma Holdings, Inc. (NDC 57237-0156-30). - Products requested: Moxifloxacin hydrochloride 400 mg tablets, 30 tablets per bottle, NSN 6505-01-503-4772. - 20 bottles under one line item. - 2 bottles under a separate line item. - Notable requirements: FDA-regulated product with a 36-month non-extendable shelf life. Store at controlled room temperature and protect from high humidity. Delivery is FOB destination within 20 days after order to separate Navy destinations.
Description
MOXIFLOXACIN HYDROC (QTY: 2, NSN: 6505-01-503-4772, Purchase Request: 7018559038) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 20, NSN: 6505-01-503-4772, Purchase Request: 7016495604) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.